文献速递核素与放射性配体治疗骨显像与常规 SPECT放射性药物与辐射防护

去势抵抗性前列腺癌患者注射二氯化镭223后骨摄取广泛并因血小板减少致死性颅内出血

Fatal Intracranial Hemorrhage Due to Thrombocytopenia in a Patient With Castration-Resistant Prostate Cancer Showing Extensive Bone Uptake of Injected 223Ra Dichloride.
PubMed 文献 · Clin Nucl Med · 2018-01-01

一例64岁去势抵抗性前列腺癌骨转移患者接受镭223注射治疗,首次注射后镭223 SPECT显示全脊柱摄取增高,脊柱与背景活性比约为其他患者正常值的3倍;第五次注射后8天,患者因严重血小板减少(血小板计数23,000/mm)发生颅内出血死亡。

要点

  • 去势抵抗性前列腺癌骨转移患者接受镭223治疗,首次注射后SPECT显示全脊柱摄取增高。
  • 该患者脊柱与背景活性比约为其他患者正常脊柱与背景活性比的3倍。
  • 第五次注射后8天,患者因严重血小板减少(血小板计数23,000/mm)发生颅内出血死亡。

核心结论

  • 该患者第五次镭223注射后8天因严重血小板减少(血小板计数23,000/mm)发生颅内出血死亡,广泛的脊柱辐射可能加重了骨髓痨过程。

研究设计与样本

  • 病例报告:一例64岁去势抵抗性前列腺癌骨转移患者接受镭223注射治疗,并进行了镭223 SPECT扫描。

主要发现

  • 首次镭223注射后SPECT显示全脊柱摄取增高,该患者脊柱与背景活性比约为其他患者正常脊柱与背景活性比的3倍。
  • 第五次注射后8天,患者神经系统检查表现极差,死于严重血小板减少(血小板计数23,000/mm)所致的颅内出血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 64-year-old man with castration-resistant prostate cancer received Ra injection to treat bone metastases. The patient underwent a Ra SPECT scan after the first Ra injection in which there was increased uptake all over the spine. Spine-to-background activity ratio in the patient was approximately three times greater than normal spine-to-background activity ratios in Ra SPECT obtained from the other patients. Eight days after the fifth injection, the patient exhibited a very poor neurologic examination and died of intracranial hemorrhage due to severe thrombocytopenia (platelet counts, 23,000/mm). The extensive radiation to the spine may have enhanced myelophthisic process in this case.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Nakahara T, Owaki Y, Kosaka T, et al. Fatal Intracranial Hemorrhage Due to Thrombocytopenia in a Patient With Castration-Resistant Prostate Cancer Showing Extensive Bone Uptake of Injected 223Ra Dichloride. Clin Nucl Med. 2018. PMID: 29742607. doi:10.1097/RLU.0000000000002117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。